Supplier
Viatris
Hoeilaart · BEL
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
Awards
10
Total awarded
€2.5m
4 joint award(s) counted pro rata
Buyers
4
Sectors
1
Group: Viatris
Reg. 0564907115
Contracts this supplier holds that are running out
- €70,925
5 Jan 2027
stated - €663,632
9 Feb 2027
stated - €374,134
9 Feb 2027
stated - €2,659,860
9 Feb 2027
stated - €1,030,991
9 Feb 2027
stated - €432,640
13 Sept 2027
estimated - €20,816
1 Aug 2030
stated - €12,262
1 Aug 2030
stated - €75,598
1 Aug 2030
stated - €24,833
13 Sept 2030
stated
Awards
| Awarded | Buyer | Winner | Contract value | Published |
|---|---|---|---|---|
| Raamovereenkomst voor het leveren van Vancomycine IV | AZORG vzw | Viatris | €75,598 | 28 Oct 2026 |
| Raamovereenkomst voor het leveren van Ciprofloxacine PO | AZORG vzw | Viatris | €12,262 | 28 Oct 2026 |
| Raamovereenkomst voor het leveren van Ceftazidime IM/IV | AZORG vzw | Viatris | €20,816 | 28 Oct 2026 |
| Levofloxacine voor oraal gebruik | UZ Leuven | Viatris | €70,925 | 14 Oct 2026 |
| Vancomycine voor intraveneuze toediening | UZ Leuven | sandoz, Viatris | €1,030,991 | 8 Oct 2026 |
| Piperacilline-Tazobactam voor intraveneuze toediening | UZ Leuven | Fresenius Kabi, sandoz, Viatris | €2,659,860 | 8 Oct 2026 |
| Ceftazidim voor intraveneuze toediening | UZ Leuven | Fresenius Kabi, sandoz, Viatris | €374,134 | 8 Oct 2026 |
| Cefazoline voor intraveneuze toediening | UZ Leuven | sandoz, Viatris | €663,632 | 8 Oct 2026 |
| Fer injectable | CHIREC | Viatris | €432,640 | 5 Oct 2026 |
| Tradonal oraal | Universitair Ziekenhuis Gent | Viatris | €24,833 | 3 Sept 2026 |